Abdominal obesity is commonly assessed using waist circumference, and common measurement protocols include the visible narrowing of the waist, last rib, top of the iliac crest, or the midpoint between the last rib and the iliac crest. Current Canadian clinical practice guidelines and the National Institutes of Health (NIH) in the United States recommend measuring waist circumference using the iliac crest as the landmark (10, 11). Accordingly, the International Chair on Cardiometabolic Risk also recommends measuring waist circumference at the top of the iliac crest. The NIH has published sex-specific waist circumference thresholds (men: 102 cm, women: 88 cm) to denote increased health risk within each BMI category (11). However, unlike BMI categories, these waist circumference cut-offs were not based on their association with morbidity or mortality, but were instead based on waist circumference values corresponding to a BMI of 30 kg/m2 in Caucasian men and women. These waist circumference thresholds seem appropriate for non-Hispanic blacks and Mexican Americans (12), but are likely too high for most Asian populations (13) and are unknown for other ethnic groups. The appropriate cut-offs for determining health risk in Asian and other ethnic populations are still being studied, but reported values for Asians range from 85 to 90 cm for men and 80 to 90 cm for women (13). For instance, the International Diabetes Federation position statement on the metabolic syndrome and its clinical diagnosis has lowered waist girth values to 94 cm for European men, while recognizing the need to propose cut-offs specific to various ethnic populations.
Within a given BMI category, individuals with a waist circumference greater than the proposed thresholds generally have a worse metabolic profile than individuals with a waist circumference below these thresholds (6). Moreover, high waist circumference predicts a later decline in insulin sensitivity over a 5 year follow-up (7). It has also been reported that once waist circumference is taken into account, BMI does not provide any added information in terms of predicting metabolic risk (8). For these reasons, it is important to measure waist circumference when assessing health risk.

Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic Risk by Vincenzo Di Marzo, PhD
More
What is the role of low HDL cholesterol in the elevated CHD risk of metabolic syndrome patients? By Philip J. Barter, MBBS, FRACP, PhD
More
Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008;32:283-91
More
Schematic representation of how smoking might add to several mechanisms linking obesity to cardiovascular disease
More